CLINICAL_TRIALS
trial_result
· 2021-05-10
Clinical Trial Update: Extension Study Of Tanezumab In Osteoarthritis [Phase 3]
Summary
Extension study results for tanezumab in osteoarthritis were reported; the study was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Osteoarthritis | Phase 3 | Status: TERMINATED | Results posted: 2021-05-10